

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | glycosphingolipid catabolic process (GO:0046479) | 6.91640422 |
| 2 | oligosaccharide catabolic process (GO:0009313) | 6.30780025 |
| 3 | glycolipid catabolic process (GO:0019377) | 6.26456777 |
| 4 | ceramide catabolic process (GO:0046514) | 5.57143211 |
| 5 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.43620944 |
| 6 | modulation by symbiont of host immune response (GO:0052553) | 5.43620944 |
| 7 | positive regulation by symbiont of host defense response (GO:0052509) | 5.43620944 |
| 8 | modulation by symbiont of host defense response (GO:0052031) | 5.43620944 |
| 9 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.43620944 |
| 10 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.43620944 |
| 11 | cellular extravasation (GO:0045123) | 5.04513851 |
| 12 | virion attachment to host cell (GO:0019062) | 4.97253620 |
| 13 | adhesion of symbiont to host cell (GO:0044650) | 4.97253620 |
| 14 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.85126562 |
| 15 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.81001803 |
| 16 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 4.79738305 |
| 17 | amino sugar catabolic process (GO:0046348) | 4.73699608 |
| 18 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 4.58312794 |
| 19 | adhesion of symbiont to host (GO:0044406) | 4.44878990 |
| 20 | membrane lipid catabolic process (GO:0046466) | 4.25858224 |
| 21 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.24379057 |
| 22 | positive regulation of mast cell activation (GO:0033005) | 4.21022166 |
| 23 | sphingolipid catabolic process (GO:0030149) | 4.15241640 |
| 24 | neutrophil activation involved in immune response (GO:0002283) | 4.12692222 |
| 25 | positive regulation of interferon-alpha production (GO:0032727) | 4.09444119 |
| 26 | apoptotic cell clearance (GO:0043277) | 4.08749570 |
| 27 | regulation of cholesterol storage (GO:0010885) | 4.01162531 |
| 28 | macrophage activation involved in immune response (GO:0002281) | 3.97060600 |
| 29 | plasma lipoprotein particle clearance (GO:0034381) | 3.95030303 |
| 30 | low-density lipoprotein particle clearance (GO:0034383) | 3.88545137 |
| 31 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.86679142 |
| 32 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.85834847 |
| 33 | regulation of interferon-alpha production (GO:0032647) | 3.85573649 |
| 34 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.85153445 |
| 35 | protein carboxylation (GO:0018214) | 3.85153445 |
| 36 | positive regulation of leukocyte degranulation (GO:0043302) | 3.80156985 |
| 37 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.78992957 |
| 38 | positive regulation of mast cell degranulation (GO:0043306) | 3.76098694 |
| 39 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.76098694 |
| 40 | aldehyde catabolic process (GO:0046185) | 3.70089408 |
| 41 | positive regulation of bone remodeling (GO:0046852) | 3.63582421 |
| 42 | positive regulation of bone resorption (GO:0045780) | 3.63582421 |
| 43 | alpha-linolenic acid metabolic process (GO:0036109) | 3.59729489 |
| 44 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.53755624 |
| 45 | L-phenylalanine catabolic process (GO:0006559) | 3.53755624 |
| 46 | response to host immune response (GO:0052572) | 3.50748191 |
| 47 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.50748191 |
| 48 | peptide catabolic process (GO:0043171) | 3.48862846 |
| 49 | negative regulation of interleukin-12 production (GO:0032695) | 3.45860733 |
| 50 | barbed-end actin filament capping (GO:0051016) | 3.45582226 |
| 51 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.44273366 |
| 52 | eosinophil chemotaxis (GO:0048245) | 3.43265511 |
| 53 | complement activation, alternative pathway (GO:0006957) | 3.43208596 |
| 54 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.42072237 |
| 55 | mannose metabolic process (GO:0006013) | 3.40732032 |
| 56 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.37937555 |
| 57 | L-phenylalanine metabolic process (GO:0006558) | 3.37937555 |
| 58 | T-helper 1 type immune response (GO:0042088) | 3.33693937 |
| 59 | respiratory burst (GO:0045730) | 3.33640143 |
| 60 | aromatic amino acid family catabolic process (GO:0009074) | 3.32390762 |
| 61 | osteoclast differentiation (GO:0030316) | 3.29947965 |
| 62 | myeloid dendritic cell differentiation (GO:0043011) | 3.29172803 |
| 63 | regulation of mast cell degranulation (GO:0043304) | 3.28468710 |
| 64 | protein localization to endosome (GO:0036010) | 3.26615155 |
| 65 | immunoglobulin mediated immune response (GO:0016064) | 3.23072257 |
| 66 | regulation of mast cell activation (GO:0033003) | 3.22648353 |
| 67 | cholesterol efflux (GO:0033344) | 3.20878451 |
| 68 | angiotensin maturation (GO:0002003) | 3.20800235 |
| 69 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.20098442 |
| 70 | urea cycle (GO:0000050) | 3.18797494 |
| 71 | urea metabolic process (GO:0019627) | 3.18797494 |
| 72 | regulation of leukocyte degranulation (GO:0043300) | 3.14421152 |
| 73 | keratan sulfate catabolic process (GO:0042340) | 3.12809840 |
| 74 | microglial cell activation (GO:0001774) | 3.12325998 |
| 75 | response to host (GO:0075136) | 3.12129418 |
| 76 | response to host defenses (GO:0052200) | 3.12129418 |
| 77 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.12129418 |
| 78 | phospholipid efflux (GO:0033700) | 3.11211879 |
| 79 | bile acid biosynthetic process (GO:0006699) | 3.10395964 |
| 80 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.10315510 |
| 81 | eosinophil migration (GO:0072677) | 3.10271994 |
| 82 | N-acetylneuraminate metabolic process (GO:0006054) | 3.10110823 |
| 83 | high-density lipoprotein particle remodeling (GO:0034375) | 3.10095939 |
| 84 | detection of other organism (GO:0098543) | 3.08757529 |
| 85 | tryptophan catabolic process (GO:0006569) | 3.06657989 |
| 86 | indole-containing compound catabolic process (GO:0042436) | 3.06657989 |
| 87 | indolalkylamine catabolic process (GO:0046218) | 3.06657989 |
| 88 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.06475590 |
| 89 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.06138109 |
| 90 | regulation of cholesterol esterification (GO:0010872) | 3.05346111 |
| 91 | positive regulation of blood coagulation (GO:0030194) | 3.04522027 |
| 92 | positive regulation of hemostasis (GO:1900048) | 3.04522027 |
| 93 | positive regulation of coagulation (GO:0050820) | 3.04255609 |
| 94 | myeloid dendritic cell activation (GO:0001773) | 3.03687738 |
| 95 | ganglioside metabolic process (GO:0001573) | 3.03605699 |
| 96 | tryptophan metabolic process (GO:0006568) | 3.03560445 |
| 97 | plasma lipoprotein particle remodeling (GO:0034369) | 3.03517440 |
| 98 | protein-lipid complex remodeling (GO:0034368) | 3.03517440 |
| 99 | macromolecular complex remodeling (GO:0034367) | 3.03517440 |
| 100 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.02632500 |
| 101 | lipoprotein transport (GO:0042953) | 3.02422511 |
| 102 | glyoxylate metabolic process (GO:0046487) | 3.02351013 |
| 103 | regulation of superoxide anion generation (GO:0032928) | 3.02250429 |
| 104 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.01423219 |
| 105 | regulation of triglyceride catabolic process (GO:0010896) | 3.00111453 |
| 106 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.99736856 |
| 107 | regulation of monocyte chemotaxis (GO:0090025) | 2.97942994 |
| 108 | positive regulation of macrophage cytokine production (GO:0060907) | 2.97289250 |
| 109 | regulation of protein activation cascade (GO:2000257) | 2.96387430 |
| 110 | response to peptidoglycan (GO:0032494) | 2.96236949 |
| 111 | reverse cholesterol transport (GO:0043691) | 2.95764878 |
| 112 | lipoxygenase pathway (GO:0019372) | 2.95376641 |
| 113 | kynurenine metabolic process (GO:0070189) | 2.95174356 |
| 114 | regulation of mononuclear cell migration (GO:0071675) | 2.95061835 |
| 115 | regulation of apoptotic cell clearance (GO:2000425) | 2.93858158 |
| 116 | nitrogen cycle metabolic process (GO:0071941) | 2.89438587 |
| 117 | negative regulation of fibrinolysis (GO:0051918) | 2.88720121 |
| 118 | macrophage differentiation (GO:0030225) | 2.88563749 |
| 119 | cysteine metabolic process (GO:0006534) | 2.87232276 |
| 120 | intracellular pH reduction (GO:0051452) | 2.86804473 |
| 121 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.85593051 |
| 122 | negative regulation of lipid storage (GO:0010888) | 2.84376385 |
| 123 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.84053761 |
| 124 | macrophage activation (GO:0042116) | 2.83519372 |
| 125 | positive regulation of lipid storage (GO:0010884) | 2.83291004 |
| 126 | positive regulation of B cell differentiation (GO:0045579) | 2.82836435 |
| 127 | regulation of complement activation (GO:0030449) | 2.82550811 |
| 128 | detection of external biotic stimulus (GO:0098581) | 2.80654240 |
| 129 | detection of molecule of bacterial origin (GO:0032490) | 2.80476201 |
| 130 | glucosamine-containing compound catabolic process (GO:1901072) | 2.80327541 |
| 131 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.80067146 |
| 132 | cofactor catabolic process (GO:0051187) | 2.79622231 |
| 133 | myeloid cell activation involved in immune response (GO:0002275) | 2.79193331 |
| 134 | sulfur amino acid catabolic process (GO:0000098) | 2.78962422 |
| 135 | fibrinolysis (GO:0042730) | 2.78959612 |
| 136 | regulation of hypersensitivity (GO:0002883) | 2.78884146 |
| 137 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.78567853 |
| 138 | positive regulation of tissue remodeling (GO:0034105) | 2.77661016 |
| 139 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.76315444 |
| 140 | plasma lipoprotein particle assembly (GO:0034377) | 2.76299522 |
| 141 | negative regulation of interleukin-17 production (GO:0032700) | 2.74680059 |
| 142 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.74197475 |
| 143 | glucuronate metabolic process (GO:0019585) | 2.73832721 |
| 144 | uronic acid metabolic process (GO:0006063) | 2.73832721 |
| 145 | reactive oxygen species biosynthetic process (GO:1903409) | 2.73201090 |
| 146 | regulation of sequestering of triglyceride (GO:0010889) | 2.73022292 |
| 147 | positive regulation of antigen processing and presentation (GO:0002579) | 2.72167360 |
| 148 | phospholipid homeostasis (GO:0055091) | 2.72145934 |
| 149 | pH reduction (GO:0045851) | 2.72015243 |
| 150 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 2.71293382 |
| 151 | low-density lipoprotein particle remodeling (GO:0034374) | 2.71072749 |
| 152 | pinocytosis (GO:0006907) | 2.70804658 |
| 153 | regulation of monocyte differentiation (GO:0045655) | 2.70444261 |
| 154 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.70362530 |
| 155 | bile acid metabolic process (GO:0008206) | 2.70307264 |
| 156 | detection of bacterium (GO:0016045) | 2.69839318 |
| 157 | iron ion import (GO:0097286) | 2.69787813 |
| 158 | phagosome maturation (GO:0090382) | 2.69595864 |
| 159 | response to thyroid hormone (GO:0097066) | 2.69371358 |
| 160 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.68867757 |
| 161 | positive regulation of lipid catabolic process (GO:0050996) | 2.68116113 |
| 162 | positive regulation of cholesterol efflux (GO:0010875) | 2.68031843 |
| 163 | lysosome organization (GO:0007040) | 2.67709464 |
| 164 | lytic vacuole organization (GO:0080171) | 2.67709464 |
| 165 | protein-lipid complex assembly (GO:0065005) | 2.67610368 |
| 166 | positive regulation of interferon-beta production (GO:0032728) | 2.66746349 |
| 167 | dendritic cell differentiation (GO:0097028) | 2.66625616 |
| 168 | lipoprotein metabolic process (GO:0042157) | 2.65352234 |
| 169 | regulation of fibrinolysis (GO:0051917) | 2.65316022 |
| 170 | plasma lipoprotein particle organization (GO:0071827) | 2.65268021 |
| 171 | monocyte chemotaxis (GO:0002548) | 2.64657530 |
| 172 | granulocyte activation (GO:0036230) | 2.63833834 |
| 173 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.61594852 |
| 174 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.61252196 |
| 175 | homocysteine metabolic process (GO:0050667) | 2.61249596 |
| 176 | protein-lipid complex subunit organization (GO:0071825) | 2.60934416 |
| 177 | response to muramyl dipeptide (GO:0032495) | 2.58701611 |
| 178 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.57996312 |
| 179 | amyloid precursor protein catabolic process (GO:0042987) | 2.57051088 |
| 180 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.56851131 |
| 181 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.55319587 |
| 182 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.54645363 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.04806459 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.39765205 |
| 3 | * IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.94915098 |
| 4 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.45104346 |
| 5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.37754504 |
| 6 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.93376835 |
| 7 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.74448138 |
| 8 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.71871064 |
| 9 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.67308843 |
| 10 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.58008088 |
| 11 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.51848967 |
| 12 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.24508524 |
| 13 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.20547934 |
| 14 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.85901529 |
| 15 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.76700068 |
| 16 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.51123312 |
| 17 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.45233780 |
| 18 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.43492011 |
| 19 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.43167274 |
| 20 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.40290310 |
| 21 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.29840088 |
| 22 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.24565574 |
| 23 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.03118575 |
| 24 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.03115564 |
| 25 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.01696370 |
| 26 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.84154358 |
| 27 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.80374348 |
| 28 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.74522061 |
| 29 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.73752839 |
| 30 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.69186245 |
| 31 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.69112147 |
| 32 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.67248114 |
| 33 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.62507806 |
| 34 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.62117457 |
| 35 | GATA1_22025678_ChIP-Seq_K562_Human | 1.57240875 |
| 36 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.53795541 |
| 37 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.50259121 |
| 38 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.49560952 |
| 39 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.44780628 |
| 40 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.44563017 |
| 41 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.44474556 |
| 42 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.44371037 |
| 43 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43730344 |
| 44 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.42954646 |
| 45 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.42176360 |
| 46 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.40643129 |
| 47 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.38188374 |
| 48 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31686807 |
| 49 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.31668325 |
| 50 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.31389971 |
| 51 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.29688008 |
| 52 | SPI1_23127762_ChIP-Seq_K562_Human | 1.28173784 |
| 53 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.28002489 |
| 54 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.24524635 |
| 55 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.24110852 |
| 56 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.22694898 |
| 57 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.22216922 |
| 58 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.21579844 |
| 59 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.20821575 |
| 60 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.19891695 |
| 61 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.19544795 |
| 62 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.17884193 |
| 63 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.17884193 |
| 64 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.16917264 |
| 65 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.11233360 |
| 66 | MAF_26560356_Chip-Seq_TH1_Human | 1.06375102 |
| 67 | MYB_26560356_Chip-Seq_TH2_Human | 1.05726561 |
| 68 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.03474590 |
| 69 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.01906444 |
| 70 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00982266 |
| 71 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.00495011 |
| 72 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.99209695 |
| 73 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.98467408 |
| 74 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.96505665 |
| 75 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.95735362 |
| 76 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.95673637 |
| 77 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.93777692 |
| 78 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.93091608 |
| 79 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.92867190 |
| 80 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.91223297 |
| 81 | GATA3_26560356_Chip-Seq_TH2_Human | 0.91058616 |
| 82 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.90598196 |
| 83 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.90116888 |
| 84 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.89376198 |
| 85 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.89120623 |
| 86 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.88771696 |
| 87 | MYB_26560356_Chip-Seq_TH1_Human | 0.88739292 |
| 88 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.87990447 |
| 89 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.87810419 |
| 90 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.87779433 |
| 91 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.85681764 |
| 92 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.85361135 |
| 93 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.84767650 |
| 94 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.84525508 |
| 95 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.83698225 |
| 96 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.83123747 |
| 97 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.82857485 |
| 98 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.82168589 |
| 99 | * GATA1_19941826_ChIP-Seq_K562_Human | 0.81222266 |
| 100 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.80231307 |
| 101 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.80142126 |
| 102 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.79721928 |
| 103 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.79705391 |
| 104 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 0.79538567 |
| 105 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.79326218 |
| 106 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.79256063 |
| 107 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.78439097 |
| 108 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.78083469 |
| 109 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.77694424 |
| 110 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.77112727 |
| 111 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.77096732 |
| 112 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.76602509 |
| 113 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.76458411 |
| 114 | UTX_26944678_Chip-Seq_JUKART_Human | 0.75544891 |
| 115 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.75500731 |
| 116 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.75468314 |
| 117 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 0.74353493 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 4.16190076 |
| 2 | MP0005360_urolithiasis | 4.08699234 |
| 3 | MP0005058_abnormal_lysosome_morphology | 3.86408143 |
| 4 | MP0009840_abnormal_foam_cell | 3.49491651 |
| 5 | MP0003191_abnormal_cellular_cholesterol | 3.02213319 |
| 6 | MP0001835_abnormal_antigen_presentation | 2.95738411 |
| 7 | MP0005365_abnormal_bile_salt | 2.94172202 |
| 8 | MP0003436_decreased_susceptibility_to | 2.92733724 |
| 9 | MP0006082_CNS_inflammation | 2.91753658 |
| 10 | MP0005085_abnormal_gallbladder_physiolo | 2.76710919 |
| 11 | MP0003303_peritoneal_inflammation | 2.64554429 |
| 12 | MP0008875_abnormal_xenobiotic_pharmacok | 2.62051446 |
| 13 | MP0003172_abnormal_lysosome_physiology | 2.49759412 |
| 14 | MP0002419_abnormal_innate_immunity | 2.40996777 |
| 15 | MP0003195_calcinosis | 2.21357232 |
| 16 | MP0009785_altered_susceptibility_to | 2.16201991 |
| 17 | MP0005083_abnormal_biliary_tract | 2.11806958 |
| 18 | * MP0010329_abnormal_lipoprotein_level | 2.06556705 |
| 19 | MP0000604_amyloidosis | 2.06180744 |
| 20 | MP0003252_abnormal_bile_duct | 1.98545326 |
| 21 | MP0005000_abnormal_immune_tolerance | 1.97063675 |
| 22 | MP0003724_increased_susceptibility_to | 1.95718839 |
| 23 | MP0005025_abnormal_response_to | 1.93170238 |
| 24 | MP0003690_abnormal_glial_cell | 1.91995982 |
| 25 | MP0002148_abnormal_hypersensitivity_rea | 1.88508384 |
| 26 | MP0008004_abnormal_stomach_pH | 1.86094800 |
| 27 | MP0005464_abnormal_platelet_physiology | 1.84157868 |
| 28 | MP0003329_amyloid_beta_deposits | 1.71943615 |
| 29 | MP0003806_abnormal_nucleotide_metabolis | 1.67257382 |
| 30 | MP0002877_abnormal_melanocyte_morpholog | 1.65705826 |
| 31 | MP0002452_abnormal_antigen_presenting | 1.65703910 |
| 32 | MP0001790_abnormal_immune_system | 1.64873693 |
| 33 | MP0005387_immune_system_phenotype | 1.64873693 |
| 34 | MP0008469_abnormal_protein_level | 1.64599586 |
| 35 | MP0009764_decreased_sensitivity_to | 1.63448850 |
| 36 | MP0001533_abnormal_skeleton_physiology | 1.58583765 |
| 37 | MP0003705_abnormal_hypodermis_morpholog | 1.56273258 |
| 38 | * MP0000609_abnormal_liver_physiology | 1.55073529 |
| 39 | MP0005332_abnormal_amino_acid | 1.53709071 |
| 40 | MP0003279_aneurysm | 1.52301309 |
| 41 | MP0003656_abnormal_erythrocyte_physiolo | 1.52231498 |
| 42 | MP0003300_gastrointestinal_ulcer | 1.51468881 |
| 43 | MP0002723_abnormal_immune_serum | 1.50410217 |
| 44 | MP0008438_abnormal_cutaneous_collagen | 1.46810074 |
| 45 | MP0001800_abnormal_humoral_immune | 1.46688171 |
| 46 | MP0000685_abnormal_immune_system | 1.46397915 |
| 47 | MP0003186_abnormal_redox_activity | 1.45942675 |
| 48 | MP0004019_abnormal_vitamin_homeostasis | 1.45268457 |
| 49 | * MP0001845_abnormal_inflammatory_respons | 1.40578553 |
| 50 | MP0003828_pulmonary_edema | 1.39783966 |
| 51 | MP0002138_abnormal_hepatobiliary_system | 1.36624050 |
| 52 | MP0005257_abnormal_intraocular_pressure | 1.35916016 |
| 53 | MP0003075_altered_response_to | 1.35618799 |
| 54 | MP0005319_abnormal_enzyme/_coenzyme | 1.34845521 |
| 55 | * MP0002118_abnormal_lipid_homeostasis | 1.31938239 |
| 56 | MP0004947_skin_inflammation | 1.31451025 |
| 57 | MP0000343_altered_response_to | 1.29510651 |
| 58 | MP0001819_abnormal_immune_cell | 1.28481228 |
| 59 | MP0002420_abnormal_adaptive_immunity | 1.26714202 |
| 60 | MP0005671_abnormal_response_to | 1.26374754 |
| 61 | MP0005166_decreased_susceptibility_to | 1.23169434 |
| 62 | MP0004510_myositis | 1.22456488 |
| 63 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.21442717 |
| 64 | MP0002998_abnormal_bone_remodeling | 1.20392384 |
| 65 | MP0003448_altered_tumor_morphology | 1.20299623 |
| 66 | MP0001853_heart_inflammation | 1.20171131 |
| 67 | MP0009763_increased_sensitivity_to | 1.18905765 |
| 68 | MP0001666_abnormal_nutrient_absorption | 1.17593384 |
| 69 | MP0003091_abnormal_cell_migration | 1.17219554 |
| 70 | MP0005647_abnormal_sex_gland | 1.15923971 |
| 71 | MP0005451_abnormal_body_composition | 1.14193317 |
| 72 | MP0009643_abnormal_urine_homeostasis | 1.13926065 |
| 73 | MP0002254_reproductive_system_inflammat | 1.13552064 |
| 74 | MP0004130_abnormal_muscle_cell | 1.12956392 |
| 75 | MP0010234_abnormal_vibrissa_follicle | 1.11474661 |
| 76 | MP0000015_abnormal_ear_pigmentation | 1.09893604 |
| 77 | MP0005167_abnormal_blood-brain_barrier | 1.09561872 |
| 78 | MP0000371_diluted_coat_color | 1.08492157 |
| 79 | MP0008260_abnormal_autophagy | 1.06483368 |
| 80 | MP0000569_abnormal_digit_pigmentation | 1.05439590 |
| 81 | MP0006054_spinal_hemorrhage | 1.02715571 |
| 82 | * MP0002405_respiratory_system_inflammati | 1.02622565 |
| 83 | MP0003011_delayed_dark_adaptation | 1.01738603 |
| 84 | * MP0000598_abnormal_liver_morphology | 1.00934124 |
| 85 | MP0003453_abnormal_keratinocyte_physiol | 0.99585229 |
| 86 | MP0010155_abnormal_intestine_physiology | 0.92734064 |
| 87 | MP0002136_abnormal_kidney_physiology | 0.92391275 |
| 88 | MP0003566_abnormal_cell_adhesion | 0.92059459 |
| 89 | MP0005164_abnormal_response_to | 0.91706416 |
| 90 | MP0002090_abnormal_vision | 0.91300943 |
| 91 | MP0000858_altered_metastatic_potential | 0.91089563 |
| 92 | MP0005165_increased_susceptibility_to | 0.90126832 |
| 93 | * MP0000716_abnormal_immune_system | 0.87147596 |
| 94 | MP0001727_abnormal_embryo_implantation | 0.86685221 |
| 95 | MP0005310_abnormal_salivary_gland | 0.86572774 |
| 96 | MP0010307_abnormal_tumor_latency | 0.86464057 |
| 97 | * MP0000689_abnormal_spleen_morphology | 0.85987313 |
| 98 | MP0004782_abnormal_surfactant_physiolog | 0.85603115 |
| 99 | MP0001849_ear_inflammation | 0.85072028 |
| 100 | MP0000465_gastrointestinal_hemorrhage | 0.84651655 |
| 101 | MP0003634_abnormal_glial_cell | 0.84535229 |
| 102 | MP0009278_abnormal_bone_marrow | 0.83492014 |
| 103 | MP0000249_abnormal_blood_vessel | 0.82046398 |
| 104 | MP0001851_eye_inflammation | 0.80467725 |
| 105 | MP0002166_altered_tumor_susceptibility | 0.79053235 |
| 106 | MP0009333_abnormal_splenocyte_physiolog | 0.78827870 |
| 107 | MP0002933_joint_inflammation | 0.77771120 |
| 108 | MP0001764_abnormal_homeostasis | 0.76561279 |
| 109 | MP0003879_abnormal_hair_cell | 0.76058821 |
| 110 | MP0003632_abnormal_nervous_system | 0.75590212 |
| 111 | MP0005174_abnormal_tail_pigmentation | 0.75321906 |
| 112 | MP0004883_abnormal_blood_vessel | 0.73859701 |
| 113 | MP0005397_hematopoietic_system_phenotyp | 0.73548805 |
| 114 | MP0001545_abnormal_hematopoietic_system | 0.73548805 |
| 115 | MP0001881_abnormal_mammary_gland | 0.73390789 |
| 116 | MP0003183_abnormal_peptide_metabolism | 0.72874888 |
| 117 | MP0003795_abnormal_bone_structure | 0.72349392 |
| 118 | MP0008874_decreased_physiological_sensi | 0.71371077 |
| 119 | MP0001756_abnormal_urination | 0.71196521 |
| 120 | * MP0009642_abnormal_blood_homeostasis | 0.70726174 |
| 121 | * MP0002429_abnormal_blood_cell | 0.70605501 |
| 122 | MP0000920_abnormal_myelination | 0.69711984 |
| 123 | MP0002398_abnormal_bone_marrow | 0.67938296 |
| 124 | MP0005390_skeleton_phenotype | 0.64998035 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.41739457 |
| 2 | Increased cerebral lipofuscin (HP:0011813) | 5.26753896 |
| 3 | Recurrent abscess formation (HP:0002722) | 4.78502401 |
| 4 | Systemic lupus erythematosus (HP:0002725) | 4.69013698 |
| 5 | Eczematoid dermatitis (HP:0000976) | 4.55131153 |
| 6 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.43834280 |
| 7 | Recurrent bacterial skin infections (HP:0005406) | 4.43009239 |
| 8 | Xanthomatosis (HP:0000991) | 4.20805343 |
| 9 | Axonal loss (HP:0003447) | 4.13177794 |
| 10 | Myocardial infarction (HP:0001658) | 3.97182498 |
| 11 | Complement deficiency (HP:0004431) | 3.97127979 |
| 12 | Joint hemorrhage (HP:0005261) | 3.94891784 |
| 13 | Dysostosis multiplex (HP:0000943) | 3.91576981 |
| 14 | Deep venous thrombosis (HP:0002625) | 3.88845564 |
| 15 | Mutism (HP:0002300) | 3.66680111 |
| 16 | * Vacuolated lymphocytes (HP:0001922) | 3.62980915 |
| 17 | Glomerulonephritis (HP:0000099) | 3.56404499 |
| 18 | Hyperlipoproteinemia (HP:0010980) | 3.51474787 |
| 19 | Mucopolysacchariduria (HP:0008155) | 3.47106736 |
| 20 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.47106736 |
| 21 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.46122238 |
| 22 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.46122238 |
| 23 | Abnormality of glycolipid metabolism (HP:0010969) | 3.46122238 |
| 24 | Intrahepatic cholestasis (HP:0001406) | 3.45756154 |
| 25 | Abnormality of complement system (HP:0005339) | 3.38269026 |
| 26 | Neurofibrillary tangles (HP:0002185) | 3.37113158 |
| 27 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.33293030 |
| 28 | Disinhibition (HP:0000734) | 3.31790739 |
| 29 | Prolonged partial thromboplastin time (HP:0003645) | 3.26979154 |
| 30 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.26741207 |
| 31 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.26741207 |
| 32 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.26741207 |
| 33 | * Abnormality of macrophages (HP:0004311) | 3.24172076 |
| 34 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.18966851 |
| 35 | Apathy (HP:0000741) | 3.09008655 |
| 36 | Autoimmune thrombocytopenia (HP:0001973) | 3.07412135 |
| 37 | Diminished motivation (HP:0000745) | 3.03241232 |
| 38 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.01234459 |
| 39 | Purpura (HP:0000979) | 2.99956806 |
| 40 | Loss of speech (HP:0002371) | 2.96627969 |
| 41 | Recurrent skin infections (HP:0001581) | 2.91064692 |
| 42 | Epidermoid cyst (HP:0200040) | 2.90258260 |
| 43 | Upper motor neuron abnormality (HP:0002127) | 2.89913226 |
| 44 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.86711735 |
| 45 | Gingivitis (HP:0000230) | 2.77702842 |
| 46 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.77083880 |
| 47 | Abnormality of the common coagulation pathway (HP:0010990) | 2.70724520 |
| 48 | Hypobetalipoproteinemia (HP:0003563) | 2.70277099 |
| 49 | Abnormality of the periventricular white matter (HP:0002518) | 2.69598492 |
| 50 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.69341254 |
| 51 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.61598383 |
| 52 | Nuclear cataract (HP:0100018) | 2.61439118 |
| 53 | Neuronal loss in central nervous system (HP:0002529) | 2.60455142 |
| 54 | Nephritis (HP:0000123) | 2.58857661 |
| 55 | Nausea (HP:0002018) | 2.58648551 |
| 56 | Conjunctival telangiectasia (HP:0000524) | 2.53036354 |
| 57 | * Hypercholesterolemia (HP:0003124) | 2.53005960 |
| 58 | Cerebral inclusion bodies (HP:0100314) | 2.49791097 |
| 59 | Gingival bleeding (HP:0000225) | 2.49012610 |
| 60 | Hypoalphalipoproteinemia (HP:0003233) | 2.47668226 |
| 61 | Peripheral demyelination (HP:0011096) | 2.42795645 |
| 62 | Hypolipoproteinemia (HP:0010981) | 2.41192944 |
| 63 | Mediastinal lymphadenopathy (HP:0100721) | 2.38917998 |
| 64 | Skin nodule (HP:0200036) | 2.36248043 |
| 65 | Pathologic fracture (HP:0002756) | 2.33809466 |
| 66 | Abnormality of the lumbar spine (HP:0100712) | 2.31379563 |
| 67 | Metaphyseal irregularity (HP:0003025) | 2.29822245 |
| 68 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.29745446 |
| 69 | Recurrent cutaneous fungal infections (HP:0011370) | 2.29745446 |
| 70 | Inappropriate behavior (HP:0000719) | 2.29405595 |
| 71 | Myositis (HP:0100614) | 2.27956926 |
| 72 | Personality changes (HP:0000751) | 2.27828629 |
| 73 | Urticaria (HP:0001025) | 2.26178196 |
| 74 | Obstructive lung disease (HP:0006536) | 2.24951424 |
| 75 | Chronic obstructive pulmonary disease (HP:0006510) | 2.24951424 |
| 76 | Amyloidosis (HP:0011034) | 2.24359973 |
| 77 | Cardiomegaly (HP:0001640) | 2.22670459 |
| 78 | Hyperammonemia (HP:0001987) | 2.21391158 |
| 79 | Progressive neurologic deterioration (HP:0002344) | 2.20323298 |
| 80 | Periodontitis (HP:0000704) | 2.19283286 |
| 81 | Agnosia (HP:0010524) | 2.17291409 |
| 82 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.16991906 |
| 83 | Dementia (HP:0000726) | 2.16866167 |
| 84 | Thoracic kyphosis (HP:0002942) | 2.16562702 |
| 85 | Hematochezia (HP:0002573) | 2.13765788 |
| 86 | Recurrent fungal infections (HP:0002841) | 2.13194269 |
| 87 | Mitral stenosis (HP:0001718) | 2.10527535 |
| 88 | Orchitis (HP:0100796) | 2.10016799 |
| 89 | Hydroxyprolinuria (HP:0003080) | 2.09694916 |
| 90 | Abnormality of proline metabolism (HP:0010907) | 2.09694916 |
| 91 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.08385733 |
| 92 | Abnormality of iron homeostasis (HP:0011031) | 2.07702916 |
| 93 | Global brain atrophy (HP:0002283) | 2.06969746 |
| 94 | Spontaneous hematomas (HP:0007420) | 2.06346009 |
| 95 | Pustule (HP:0200039) | 2.05525714 |
| 96 | Menorrhagia (HP:0000132) | 2.04748595 |
| 97 | Tetraparesis (HP:0002273) | 2.03078555 |
| 98 | Sensorimotor neuropathy (HP:0007141) | 2.02838200 |
| 99 | Basal ganglia calcification (HP:0002135) | 2.01665315 |
| 100 | Abnormality of the intrinsic pathway (HP:0010989) | 2.01181931 |
| 101 | Hepatocellular carcinoma (HP:0001402) | 1.99786333 |
| 102 | Increased serum ferritin (HP:0003281) | 1.99071920 |
| 103 | Petechiae (HP:0000967) | 1.98735750 |
| 104 | Abnormality of purine metabolism (HP:0004352) | 1.98455129 |
| 105 | Poor head control (HP:0002421) | 1.97410217 |
| 106 | Retinal atrophy (HP:0001105) | 1.96661138 |
| 107 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.96657787 |
| 108 | Conjugated hyperbilirubinemia (HP:0002908) | 1.95709783 |
| 109 | * Hepatosplenomegaly (HP:0001433) | 1.95602351 |
| 110 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.93533786 |
| 111 | Increased CSF protein (HP:0002922) | 1.93029126 |
| 112 | Ketosis (HP:0001946) | 1.92436619 |
| 113 | Abnormality of nucleobase metabolism (HP:0010932) | 1.90992608 |
| 114 | Mucosal telangiectasiae (HP:0100579) | 1.90876611 |
| 115 | J-shaped sella turcica (HP:0002680) | 1.88825987 |
| 116 | Asymmetric septal hypertrophy (HP:0001670) | 1.86081036 |
| 117 | Progressive visual loss (HP:0000529) | 1.85792380 |
| 118 | Bone pain (HP:0002653) | 1.85612619 |
| 119 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.85447936 |
| 120 | Pulmonary embolism (HP:0002204) | 1.85378555 |
| 121 | Abnormality of methionine metabolism (HP:0010901) | 1.84840071 |
| 122 | Pulmonary infiltrates (HP:0002113) | 1.84699459 |
| 123 | Prostate neoplasm (HP:0100787) | 1.82890235 |
| 124 | T lymphocytopenia (HP:0005403) | 1.82289044 |
| 125 | Polygenic inheritance (HP:0010982) | 1.80954136 |
| 126 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.77635432 |
| 127 | Vertebral compression fractures (HP:0002953) | 1.77277208 |
| 128 | Polyneuropathy (HP:0001271) | 1.74197271 |
| 129 | Meningitis (HP:0001287) | 1.74079890 |
| 130 | Multiple enchondromatosis (HP:0005701) | 1.73866211 |
| 131 | Osteolytic defects of the hand bones (HP:0009699) | 1.73591731 |
| 132 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.73591731 |
| 133 | Hemoptysis (HP:0002105) | 1.73445639 |
| 134 | Premature loss of primary teeth (HP:0006323) | 1.71101235 |
| 135 | Ovoid vertebral bodies (HP:0003300) | 1.70924838 |
| 136 | Prolonged neonatal jaundice (HP:0006579) | 1.70168763 |
| 137 | Abnormality of the prostate (HP:0008775) | 1.68920348 |
| 138 | Spondylolisthesis (HP:0003302) | 1.67905502 |
| 139 | Albinism (HP:0001022) | 1.67753598 |
| 140 | Amaurosis fugax (HP:0100576) | 1.66029477 |
| 141 | Thin bony cortex (HP:0002753) | 1.65142475 |
| 142 | Retrobulbar optic neuritis (HP:0100654) | 1.65061485 |
| 143 | Optic neuritis (HP:0100653) | 1.65061485 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 3.51729796 |
| 2 | TBK1 | 3.25004416 |
| 3 | KIT | 3.02981098 |
| 4 | RIPK4 | 2.87235463 |
| 5 | TYK2 | 2.83978662 |
| 6 | MAP3K14 | 2.75340209 |
| 7 | PBK | 2.67610761 |
| 8 | BLK | 2.65110507 |
| 9 | NEK9 | 2.34328941 |
| 10 | MAP4K1 | 2.23144396 |
| 11 | TGFBR2 | 2.21441583 |
| 12 | IRAK4 | 2.19214017 |
| 13 | ACVR1B | 2.16716836 |
| 14 | IRAK3 | 2.11568931 |
| 15 | TRIB3 | 2.11070922 |
| 16 | PRPF4B | 2.04891582 |
| 17 | TAOK3 | 2.02128265 |
| 18 | FGFR4 | 1.99444755 |
| 19 | PKN2 | 1.95901973 |
| 20 | NME2 | 1.93490548 |
| 21 | JAK1 | 1.82521593 |
| 22 | IKBKE | 1.70902538 |
| 23 | PDK2 | 1.67866887 |
| 24 | CSF1R | 1.66383475 |
| 25 | CDC42BPA | 1.62624871 |
| 26 | JAK3 | 1.57065286 |
| 27 | DDR2 | 1.55826935 |
| 28 | BCKDK | 1.54462461 |
| 29 | IKBKB | 1.52331697 |
| 30 | SIK1 | 1.52128379 |
| 31 | ZAP70 | 1.50908886 |
| 32 | ABL2 | 1.50679710 |
| 33 | CSK | 1.50306528 |
| 34 | EPHB1 | 1.48746790 |
| 35 | CAMK1D | 1.47554923 |
| 36 | LIMK1 | 1.45163070 |
| 37 | RIPK1 | 1.44369579 |
| 38 | MAP2K3 | 1.43901325 |
| 39 | JAK2 | 1.37757632 |
| 40 | MST1R | 1.26284753 |
| 41 | HCK | 1.25572882 |
| 42 | SYK | 1.23247043 |
| 43 | ADRBK2 | 1.20832063 |
| 44 | PTK6 | 1.20629970 |
| 45 | PIM2 | 1.20317776 |
| 46 | MAP3K13 | 1.14082777 |
| 47 | TESK2 | 1.06675168 |
| 48 | LYN | 1.05799818 |
| 49 | RPS6KA2 | 1.05290959 |
| 50 | BTK | 1.05222517 |
| 51 | STK10 | 1.04155105 |
| 52 | TTN | 1.00300025 |
| 53 | TXK | 0.99381961 |
| 54 | LCK | 0.98308920 |
| 55 | BMX | 0.97224644 |
| 56 | BMPR2 | 0.97151697 |
| 57 | MAP3K3 | 0.96092797 |
| 58 | LRRK2 | 0.95566735 |
| 59 | ARAF | 0.94912550 |
| 60 | ITK | 0.93383411 |
| 61 | KDR | 0.93232810 |
| 62 | ERBB4 | 0.90302782 |
| 63 | SCYL2 | 0.88254828 |
| 64 | FGR | 0.87686183 |
| 65 | FES | 0.87146923 |
| 66 | GRK6 | 0.86330438 |
| 67 | TRPM7 | 0.85376022 |
| 68 | FLT3 | 0.84579178 |
| 69 | FGFR3 | 0.83429488 |
| 70 | MAP3K11 | 0.83023387 |
| 71 | TEC | 0.82734157 |
| 72 | EGFR | 0.81379539 |
| 73 | CDK6 | 0.80101960 |
| 74 | TESK1 | 0.77181745 |
| 75 | PIK3CG | 0.77123493 |
| 76 | MATK | 0.75685197 |
| 77 | CAMK1G | 0.74680496 |
| 78 | CHUK | 0.73896375 |
| 79 | ABL1 | 0.73090335 |
| 80 | RPS6KA4 | 0.69799330 |
| 81 | PRKCD | 0.68968236 |
| 82 | MAP3K2 | 0.68792768 |
| 83 | PIM1 | 0.65064088 |
| 84 | PRKG2 | 0.64855182 |
| 85 | RPS6KC1 | 0.63592570 |
| 86 | RPS6KL1 | 0.63592570 |
| 87 | PDPK1 | 0.61323057 |
| 88 | SGK3 | 0.60803315 |
| 89 | STK4 | 0.57873980 |
| 90 | YES1 | 0.57682930 |
| 91 | MAPK12 | 0.57316269 |
| 92 | MAP3K8 | 0.57020518 |
| 93 | EPHA3 | 0.55085284 |
| 94 | TAOK1 | 0.54890392 |
| 95 | MARK3 | 0.53948611 |
| 96 | IRAK2 | 0.53655874 |
| 97 | IGF1R | 0.53257553 |
| 98 | PRKCQ | 0.52722372 |
| 99 | MAPK11 | 0.51191516 |
| 100 | MAPK7 | 0.50836866 |
| 101 | PRKCH | 0.50330978 |
| 102 | PDK1 | 0.50258976 |
| 103 | STK3 | 0.48554361 |
| 104 | GSK3A | 0.48085429 |
| 105 | MAP3K5 | 0.46668129 |
| 106 | DAPK2 | 0.46165079 |
| 107 | RPS6KA6 | 0.45596080 |
| 108 | MOS | 0.45574212 |
| 109 | PDGFRB | 0.44633217 |
| 110 | PDGFRA | 0.44391752 |
| 111 | PAK4 | 0.44110640 |
| 112 | CAMKK1 | 0.43547255 |
| 113 | FYN | 0.43519712 |
| 114 | GRK7 | 0.43359453 |
| 115 | MAPKAPK2 | 0.42510131 |
| 116 | MAP3K1 | 0.42404465 |
| 117 | CAMKK2 | 0.40485848 |
| 118 | DYRK1B | 0.40308899 |
| 119 | MAP3K6 | 0.39052820 |
| 120 | MAP3K10 | 0.38736903 |
| 121 | FER | 0.37603097 |
| 122 | MAPK4 | 0.37535536 |
| 123 | KSR1 | 0.33453233 |
| 124 | CLK1 | 0.31020125 |
| 125 | SRC | 0.28854005 |
| 126 | TAOK2 | 0.28837188 |
| 127 | KSR2 | 0.28139803 |
| 128 | DAPK3 | 0.27218475 |
| 129 | PRKACG | 0.26373073 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.73415771 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.20203170 |
| 3 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.94057278 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.75141803 |
| 5 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.56434660 |
| 6 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.50687197 |
| 7 | * Lysosome_Homo sapiens_hsa04142 | 2.45456026 |
| 8 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.43514267 |
| 9 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.26492997 |
| 10 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.18040775 |
| 11 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.96934833 |
| 12 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.92216447 |
| 13 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.92174463 |
| 14 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.82506788 |
| 15 | Leishmaniasis_Homo sapiens_hsa05140 | 1.80224155 |
| 16 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.79974433 |
| 17 | Other glycan degradation_Homo sapiens_hsa00511 | 1.77692225 |
| 18 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.72994313 |
| 19 | Histidine metabolism_Homo sapiens_hsa00340 | 1.59979229 |
| 20 | Peroxisome_Homo sapiens_hsa04146 | 1.58878693 |
| 21 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.51469550 |
| 22 | Phagosome_Homo sapiens_hsa04145 | 1.49022265 |
| 23 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.48656259 |
| 24 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.46393809 |
| 25 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.43881756 |
| 26 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.40473639 |
| 27 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.36167695 |
| 28 | Tuberculosis_Homo sapiens_hsa05152 | 1.35566679 |
| 29 | Pertussis_Homo sapiens_hsa05133 | 1.32366067 |
| 30 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.31397142 |
| 31 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.30317262 |
| 32 | Viral myocarditis_Homo sapiens_hsa05416 | 1.29179253 |
| 33 | Malaria_Homo sapiens_hsa05144 | 1.28454655 |
| 34 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.28215221 |
| 35 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.25774656 |
| 36 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.25626056 |
| 37 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.21185920 |
| 38 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.21098715 |
| 39 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.20968632 |
| 40 | Legionellosis_Homo sapiens_hsa05134 | 1.19542833 |
| 41 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.18657231 |
| 42 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.16011517 |
| 43 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.14366463 |
| 44 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.13103785 |
| 45 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.07687822 |
| 46 | Retinol metabolism_Homo sapiens_hsa00830 | 1.06669459 |
| 47 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.06426556 |
| 48 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.03901579 |
| 49 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.01967594 |
| 50 | Bile secretion_Homo sapiens_hsa04976 | 0.99285018 |
| 51 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.98244376 |
| 52 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.98101178 |
| 53 | ABC transporters_Homo sapiens_hsa02010 | 0.94599318 |
| 54 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.92791604 |
| 55 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.88225009 |
| 56 | * Steroid biosynthesis_Homo sapiens_hsa00100 | 0.87927398 |
| 57 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.81245280 |
| 58 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.80356713 |
| 59 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.78365652 |
| 60 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.77297755 |
| 61 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.77105405 |
| 62 | Measles_Homo sapiens_hsa05162 | 0.77066777 |
| 63 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.75787600 |
| 64 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.74232764 |
| 65 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.73710073 |
| 66 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.73538323 |
| 67 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.73298986 |
| 68 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.70712215 |
| 69 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.70182083 |
| 70 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.67183324 |
| 71 | Salmonella infection_Homo sapiens_hsa05132 | 0.66807895 |
| 72 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.66323788 |
| 73 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.65866996 |
| 74 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.64915767 |
| 75 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.64733605 |
| 76 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.64584294 |
| 77 | Platelet activation_Homo sapiens_hsa04611 | 0.64131495 |
| 78 | Apoptosis_Homo sapiens_hsa04210 | 0.62308397 |
| 79 | Carbon metabolism_Homo sapiens_hsa01200 | 0.61687123 |
| 80 | Influenza A_Homo sapiens_hsa05164 | 0.61672064 |
| 81 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.61215148 |
| 82 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.61213112 |
| 83 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.61034729 |
| 84 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.60982237 |
| 85 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.60390464 |
| 86 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.60324960 |
| 87 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.59609433 |
| 88 | Prion diseases_Homo sapiens_hsa05020 | 0.57297184 |
| 89 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.56669730 |
| 90 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.55775030 |
| 91 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.55471097 |
| 92 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.55324355 |
| 93 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.54142606 |
| 94 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.53287452 |
| 95 | Mineral absorption_Homo sapiens_hsa04978 | 0.53069006 |
| 96 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.52919188 |
| 97 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.52707583 |
| 98 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.52234169 |
| 99 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.52119558 |
| 100 | Galactose metabolism_Homo sapiens_hsa00052 | 0.52066912 |
| 101 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.51480409 |
| 102 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.50744925 |
| 103 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.50632029 |
| 104 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.49565905 |
| 105 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.49484902 |
| 106 | Hepatitis C_Homo sapiens_hsa05160 | 0.48206443 |
| 107 | Asthma_Homo sapiens_hsa05310 | 0.47674282 |
| 108 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.47601815 |
| 109 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.47306877 |
| 110 | Amoebiasis_Homo sapiens_hsa05146 | 0.46364683 |
| 111 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.45881271 |
| 112 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.45667495 |
| 113 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.45376346 |
| 114 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.45241424 |
| 115 | Allograft rejection_Homo sapiens_hsa05330 | 0.45064658 |
| 116 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.43985932 |
| 117 | Shigellosis_Homo sapiens_hsa05131 | 0.43752456 |
| 118 | Endocytosis_Homo sapiens_hsa04144 | 0.42774041 |
| 119 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.42621406 |
| 120 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.42618278 |
| 121 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.41343824 |
| 122 | Hepatitis B_Homo sapiens_hsa05161 | 0.40164553 |
| 123 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.39426364 |
| 124 | Lysine degradation_Homo sapiens_hsa00310 | 0.39018021 |
| 125 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.38347422 |
| 126 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.37966146 |
| 127 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.37105911 |
| 128 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.36637782 |
| 129 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.36309557 |
| 130 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.34965937 |
| 131 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.33746276 |
| 132 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.28777086 |
| 133 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.28616513 |
| 134 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.25443554 |
| 135 | Insulin resistance_Homo sapiens_hsa04931 | 0.24761503 |
| 136 | Bladder cancer_Homo sapiens_hsa05219 | 0.24015349 |
| 137 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.23708530 |
| 138 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.22419122 |
| 139 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.22259736 |
| 140 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.20684202 |
| 141 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.20613837 |
| 142 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.20271811 |
| 143 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.20061307 |
| 144 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.20012142 |
| 145 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.19307285 |

